77
Participants
Start Date
October 31, 2004
Primary Completion Date
April 30, 2010
Study Completion Date
April 30, 2015
Sodium Stibogluconate (SSG)
100 mg/ml/vial. Treatment for laboratory-confirmed leishmaniasis with SSG 20mg/kg/d intravenously (IV) for 10 days or 20 days; visceral leishmaniasis will be treated with SSG 20mg/kg/d IV for 28 days as a second line of therapy for those failing or intolerant of Ambisome; and mucosal leishmaniasis will be treated with SSG 20mg/kg/d IV for 28 days.
Walter Reed National Military Medical Center, Washington D.C.
Walter Reed Army Medical Center
FED
U.S. Army Medical Research and Development Command
FED